# A Study Investigating Whether Low Dose Eyedrops for Pupil Dilation is as Effective and Safe as Standard Dose Eyedrops in Examination for Retinopathy of Prematurity.

> **NCT06288321** · EARLY_PHASE1 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 18 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Microdrop Mydrin-P
- **DRUG:** Standard Mydrin-P

## Key facts

- **NCT ID:** NCT06288321
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-10
- **Primary completion:** 2023-03-22
- **Final completion:** 2023-03-22
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06288321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06288321, "A Study Investigating Whether Low Dose Eyedrops for Pupil Dilation is as Effective and Safe as Standard Dose Eyedrops in Examination for Retinopathy of Prematurity.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06288321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*